• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于计数的母体血浆DNA大小校正分析,用于改善胎儿13、18和21三体的无创产前检测。

Count-based size-correction analysis of maternal plasma DNA for improved noninvasive prenatal detection of fetal trisomies 13, 18, and 21.

作者信息

Zhang Li, Zhu Qian, Wang He, Liu Shanling

机构信息

West China Second University Hospital, Sichuan UniversityChengdu, Sichuan, China.

The First People's Hospital of ChengduChengdu, Sichuan, China.

出版信息

Am J Transl Res. 2017 Jul 15;9(7):3469-3473. eCollection 2017.

PMID:28804563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5527261/
Abstract

PURPOSE

Our goal was to derive more sensitive and accurate Z-scores based on combined DNA count- and size-based algorithms to advance molecular diagnostics for noninvasive prenatal testing of fetal trisomies.

METHODS

We included 180 cases at high risk for fetal aneuploidy who underwent amniotic fluid cytogenetic analysis. We calculated their traditional count-based Z-scores, as well as their 100-, 130- and 150-, and 166-bp size-corrected Z-scores, and determined each Z-score's reliability based on its comparison to the cases' cytogenetic results.

RESULTS

We detected for trisomies 13, 18, or 21 among the 180 cases in our study by amniotic testing and DNA sequence analysis. None trisomies 13 was detected, while 1 case of trisomies 18 and 3 cases of trisomies 21 were found. The sensitivity, specificity, and accuracy of traditional count-based Z-scores were 75%, 98.86%, and 98.33%, respectively, while these rates increased to 80%, 99.43%, and 99.44% with a count-based 100- and 166-bp size correction. Moreover, the sensitivity, specificity, and accuracy of count-based Z-scores with 130- and 150-bp size corrections were 100%, and neither of these algorithms yielded false positive trisomies, unlike other evaluated size correction Z-scores.

CONCLUSIONS

Count-based Z-scores with 130- and 150-bp size corrections more robustly predict fetal trisomies than count-based methods alone or those combined with other size-correction cutoffs, such as 166 bp. These testing parameters may enhance the utility of DNA sequence-based methods for noninvasive prenatal detection of fetal trisomies.

摘要

目的

我们的目标是基于结合DNA计数和大小的算法得出更敏感、准确的Z分数,以推进胎儿三体非侵入性产前检测的分子诊断。

方法

我们纳入了180例胎儿非整倍体高风险病例,这些病例均接受了羊水细胞遗传学分析。我们计算了他们基于传统计数的Z分数,以及100、130、150和166碱基对大小校正后的Z分数,并通过与病例的细胞遗传学结果比较来确定每个Z分数的可靠性。

结果

通过羊水检测和DNA序列分析,我们在研究的180例病例中检测出13、18或21三体。未检测到13三体,而发现1例18三体和3例21三体。基于传统计数的Z分数的敏感性、特异性和准确性分别为75%、98.86%和98.33%,而基于计数的100和166碱基对大小校正后,这些比率分别提高到80%、99.43%和99.44%。此外,基于130和150碱基对大小校正的计数Z分数的敏感性、特异性和准确性均为100%,与其他评估的大小校正Z分数不同,这些算法均未产生假阳性三体。

结论

基于130和150碱基对大小校正的计数Z分数比单独的基于计数的方法或与其他大小校正临界值(如166碱基对)结合的方法更能可靠地预测胎儿三体。这些检测参数可能会提高基于DNA序列的方法在胎儿三体非侵入性产前检测中的效用。

相似文献

1
Count-based size-correction analysis of maternal plasma DNA for improved noninvasive prenatal detection of fetal trisomies 13, 18, and 21.基于计数的母体血浆DNA大小校正分析,用于改善胎儿13、18和21三体的无创产前检测。
Am J Transl Res. 2017 Jul 15;9(7):3469-3473. eCollection 2017.
2
[Improvement of algorithm based on free DNA fragment size for non-invasive prenatal test].基于游离DNA片段大小的无创产前检测算法改进
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Jun 10;37(6):609-612. doi: 10.3760/cma.j.issn.1003-9406.2020.06.003.
3
Contribution of maternal copy number variations to false-positive fetal trisomies detected by noninvasive prenatal testing.母体拷贝数变异对无创产前检测中检测到的假阳性胎儿三体的影响。
Prenat Diagn. 2017 Apr;37(4):318-322. doi: 10.1002/pd.5014. Epub 2017 Feb 24.
4
Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.利用DNA大规模平行基因组测序技术对孕妇血液进行无创产前筛查,以检测胎儿21三体、18三体、13三体及常见性染色体非整倍体。
Am J Obstet Gynecol. 2014 Oct;211(4):365.e1-12. doi: 10.1016/j.ajog.2014.03.042. Epub 2014 Mar 19.
5
Analysis of the accuracy of Z-scores of non-invasive prenatal testing for fetal Trisomies 13, 18, and 21 that employs the ion proton semiconductor sequencing platform.采用离子质子半导体测序平台的胎儿13、18和21三体非侵入性产前检测Z值准确性分析。
Mol Cytogenet. 2018 Aug 25;11:49. doi: 10.1186/s13039-018-0397-x. eCollection 2018.
6
An adaptive detection method for fetal chromosomal aneuploidy using cell-free DNA from 447 Korean women.一种利用447名韩国女性游离DNA检测胎儿染色体非整倍体的自适应检测方法。
BMC Med Genomics. 2016 Oct 3;9(1):61. doi: 10.1186/s12920-016-0222-5.
7
Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management.使用新型分析流程进行非侵入性产前检测以筛查所有常染色体胎儿非整倍体可改善妊娠管理。
Eur J Hum Genet. 2015 Oct;23(10):1286-93. doi: 10.1038/ejhg.2014.282. Epub 2015 Jan 14.
8
Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.一种DNA方法——荧光定量聚合酶链反应(QF-PCR)在胎儿非整倍体产前诊断中的应用。
J Obstet Gynaecol Can. 2011 Sep;33(9):955-960. doi: 10.1016/S1701-2163(16)35022-8.
9
[Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].游离胎儿DNA在母体血浆中用于无创产前诊断的临床应用
Zhonghua Fu Chan Ke Za Zhi. 2012 Nov;47(11):813-7.
10
Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.通过母体血浆DNA测序对常见胎儿染色体非整倍体进行无创产前诊断。
J Matern Fetal Neonatal Med. 2012 Aug;25(8):1370-4. doi: 10.3109/14767058.2011.635730. Epub 2012 Feb 24.

引用本文的文献

1
Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.游离 DNA 大小谱:指导临床检测实践和创新的灯塔。
Theranostics. 2020 Mar 26;10(11):4737-4748. doi: 10.7150/thno.42565. eCollection 2020.
2
Recent trends in prenatal genetic screening and testing.产前基因筛查与检测的近期趋势
F1000Res. 2019 May 31;8. doi: 10.12688/f1000research.16837.1. eCollection 2019.
3
Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing.大小标记的母体外周血游离 DNA 偏好末端揭示了其产生机制,并在无创产前检测中具有实用价值。
Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5106-E5114. doi: 10.1073/pnas.1804134115. Epub 2018 May 14.

本文引用的文献

1
Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus.检测母血中游离胎儿DNA用于高危胎儿唐氏综合征、爱德华兹综合征和帕陶氏综合征的筛查
Int J Clin Exp Med. 2015 Jun 15;8(6):9525-30. eCollection 2015.
2
Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center.三级转诊中心非侵入性产前检测(NIPT)的应用及其对侵入性检查的影响。
Arch Gynecol Obstet. 2015 Sep;292(3):543-8. doi: 10.1007/s00404-015-3674-5. Epub 2015 Feb 26.
3
Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing.基于大小的分子诊断技术,利用血浆 DNA 进行无创性产前检测。
Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8583-8. doi: 10.1073/pnas.1406103111. Epub 2014 May 19.
4
Rapid detection of aneuploidy and unbalanced chromosomal rearrangements by subtelomeric multiplex ligation-dependent probe amplification in fetuses with congenital heart disease.应用端粒多重连接依赖探针扩增技术快速检测先天性心脏病胎儿的非整倍体和染色体不平衡重排。
Fetal Diagn Ther. 2013;34(2):110-5. doi: 10.1159/000350272. Epub 2013 Jun 13.
5
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies.母体外周血游离胎儿 DNA 片段对常见胎儿非整倍体的下一代测序检测的影响。
Prenat Diagn. 2013 Jul;33(7):667-74. doi: 10.1002/pd.4126. Epub 2013 May 31.
6
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.母体外周血游离 DNA 测序用于唐氏综合征的检测:一项国际临床验证研究。
Genet Med. 2011 Nov;13(11):913-20. doi: 10.1097/GIM.0b013e3182368a0e.
7
Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study.应用多重母体外周血游离 DNA 测序进行非侵入性产前唐氏综合征 21 三体的检测:大规模有效性研究。
BMJ. 2011 Jan 11;342:c7401. doi: 10.1136/bmj.c7401.
8
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus.母体外周血游离 DNA 测序揭示胎儿全基因组遗传和突变特征。
Sci Transl Med. 2010 Dec 8;2(61):61ra91. doi: 10.1126/scitranslmed.3001720.
9
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.通过对母血中DNA进行大规模平行基因组测序实现胎儿染色体非整倍体的无创产前诊断。
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20458-63. doi: 10.1073/pnas.0810641105. Epub 2008 Dec 10.
10
Size distributions of maternal and fetal DNA in maternal plasma.孕妇血浆中母体和胎儿DNA的大小分布。
Clin Chem. 2004 Jan;50(1):88-92. doi: 10.1373/clinchem.2003.024893.